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Introduction
　Acute respiratory distress syndrome (ARDS) is a type of 
acute diffuse inflammatory lung injury leading to increased 
pulmonary vascular permeability, increased lung weight, 
and loss of aerated lung tissue that can require intensive care 
and in the worst case be lethal [1, 2]. The alveolar-capillary 
barrier consists of two separate barriers, the alveolar epithe-
lium and the microvascular endothelium. Pulmonary edema 
is caused by either alveolar or vesicular injuries, although 
the mechanisms underlying the pathogenesis are not clearly 
understood. Direct injuries of the pulmonary epithelium 
such as that caused during pneumonia increase the permea-
bility of lung microvessels, while indirect disorders such as 
sepsis or other severe inflammatory disorders within the mi-
crovessels result in injuries to vascular endocapillary cells 
and alveolar endothelial cells. Intra-tracheal administration 
of lipopolysaccharide (LPS), which induces the activation of 
innate immunity in intrabronchial cells, is often used as a 
model of ARDS [3]. LPS forms a complex with LPS-binding 
protein (LBP) and CD14 on the cell surface and stimulates 
the complex formation of toll-like receptor 4 (TLR4) with 
the lipid-binding protein MD2 [4, 5]. This receptor-mediated 
TLR4/MD2 clustering in lung cells, including pulmonary 
epithelial cells, dendritic cells (DCs), and macrophages, in-
duces their production of cytokines and chemokines and re-
cruits various immune cells to the pulmonary tissue, culmi-
nating in the development of ARDS-like diseases [6-9].
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　UT12 is an agonistic monoclonal antibody (mAb) specific 
for the TLR4/MD2 complex, which stimulates the TLR4 
signaling pathway through NF-κB activation and induces 
the production of pro-inflammatory cytokines [10, 11]. 
UT12 binds to the TLR4/MD2 complex and therefore by it-
self triggers the activation signals in a manner restricted only 
by this antibody-receptor complex. The TLR4-mediated im-
mune response induced by UT12 is slightly different from 
that induced by LPS. LPS tolerance is transiently induced in 
animals administered with low doses of LPS, while UT12 
can induce prolonged  unresponsive state [10]. In the present 
study, we examined the mobilization of immune cells in the 
lung following TLR4 signaling via intratracheal stimulation 
by two distinct methods, namely administration of LPS or 
UT12. 
Materials and Methods
Cell culture, ELISA, and antibodies
　RAW264.7 cells (1×105) were cultured in a 96-well flat-
bottom plate in the presence or absence of UT12 (0.001–10 
µg/mL) and LPS (0.001–1 µg/mL, from Pseudomonas 
aeruginosa 10, Sigma-Aldrich, St. Louis, MO, USA) for 24 
h. The IL-6 and IL-12 levels in the supernatant were deter-
mined by a sandwich ELISA as previously described [12].  
For UT12 mAb collection, hybridoma cells were injected 
intraperitoneally into SCID mice and the IgG fraction was 
purified from the ascites using T-GEL MacroPAC (Scipac, 
Sittingbourne, UK) as previously described [10].
Animals
　MyD88−/−and TRIF−/− mice were provided by Drs. S. 
Akira and T. Takeda (Osaka University, Osaka, Japan) [13, 
14].  C57BL/6 (B6) mice were purchased from SLC (Shi-
zuoka, Japan). The animals were maintained in the Labora-
tory Animal Center of Nagasaki University (LACNU). Mice 
were anesthetized by intraperitoneal administration of pen-
tobarbital sodium salt (40 mg/kg), and the external tube of a 
24G intravascular indwelling needle (BD Biosciences, San 
Diego, CA, USA) was inserted into the trachea as described 
previously with some modifications [15]. Saline solution (50 
μL) containing UT12 (10 – 0.1 μg) or LPS (100 – 0.1 μg) 
was injected into the trachea. Mice were sacrificed 2 or 7 
days after administration, and both lungs were collected. 
The animal experiments were approved by the Ethics Re-
view Committee for Animal Experimentation of Nagasaki 
University, and were conducted in accordance with the 
guidelines for animal experimentation of LACNU.
Cell preparation and flow cytometry
　Lung tissue was immersed in RPMI1640 medium con-
taining collagenase (10 mg/mL, SERVA, Heidelberg, Ger-
many), finely minced, and incubated at 37 ℃ for 30 min as 
described previously [12]. After filtration and centrifugation, 
cells were treated with Geyʼs solution to lyse red blood cells, 
washed with RPMI1640, and resuspended in PBS contain-
ing 0.5 % BSA, 2 mM EDTA, and 0.09% sodium azide. 
Cells were stained with FITC-anti-CD11c, PE-anti-Ly6G 
(Gr-1), FITC-anti-F4/80, or FITC-anti-CD45R (B220) mAbs, 
or with biotin-anti-CD11b, biotin-anti-TCRβ, and allophy-
cocyanin-streptavidin (all from e-Biosciences, San Diego, 
CA, USA). After washing, 7-amino-actinomycin D (7AAD) 
was added to exclude dead cells, and samples were analyzed 




　Data are expressed as mean ± standard deviation (SD). 
LPS-treated, UT12-treated and control groups were first 
compared by one-way analysis of variance (ANOVA) at a 
significance level of 0.05, and, if significant, Holm-Sidakʼs 
multiple comparisons test was used to draw comparisons be-
tween each pair in the group. Differences between two 
groups were analyzed by an unpaired t-test. A two-tailed p-
value of less than 0.05 was considered significant. All statis-
tical analyses were conducted using GraphPad Prism version 
6.0 (GraphPad Software, San Diego, CA, USA).
Results
Differential cellular responses to LPS and UT12
　The RAW264 macrophage cell line was stimulated with 
different doses of LPS or UT12, and the production of cy-
tokines in vitro was determined (Fig. 1). IL-6 and IL-12 lev-
els in the supernatant increased in a dose-dependent manner 
in response to both LPS and UT12 treatment. Nonetheless, 
the maximum levels of IL-6 and IL-12 produced in response 
to LPS were approximately 14 and 6 times higher, respec-
tively, than those produced in response to UT12. We next 
examined the effects of intra-tracheal LPS or UT12 adminis-
　　　　　　　　　　　
Abbreviations: ARDS, acute respiratory distress syndrome; DCs, dendritic 
cells; LPS, lipopolysaccharide; mAb, monoclonal antibody
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tration on lung infiltration of immune cells in vivo (Fig. 2). 
The number of infiltrating cells in the lung increased in a 
dose-dependent manner when the doses of LPS and UT12 
were below 1 µg/mouse and plateaued at higher doses. The 
total number of infiltrating cells in response to LPS was gen-
erally higher compared with UT12, although the differences 
were not statistically significant. We focused on neutrophil 
(Gr1+F4/80−cells) infiltration because they represent the 
major cell type accumulating in the lung during ARDS [2]. 
The neutrophil proportion of all infiltrating cells was similar 
after administration of LPS or UT12 at doses below 1 µg/
mouse. In contrast, the proportion of neutrophils increased 
in a dose-dependent manner at higher LPS doses, while it 
reached a maximum level at 1 µg/mouse of UT12 and did 
not increase at higher doses. In addition, the peak proportion 
of neutrophils in the lung-infiltrating cells of UT12-treated 
mice (approximately 47%) was lower than that of LPS-treat-
ed mice (approximately 75%).
Infiltrating cells in the lung after administration of LPS 
or UT12
 
　Since the number of infiltrating cells in the lung reached 
maximum levels 2–3 days after LPS treatment (data not 
shown), we examined the infiltrating cells in more detail at 2 
and 7 days after intra-tracheal administration of LPS or 
UT12. Cells were stained with their respective markers, and 
the proportions of Gr1+F4/80− cells (neutrophils), CD11blo
CD11c＋cells, CD11bhiCD11c＋cells, TCRβ+ cells (T cells), 
and B220+ cells (B cells) were determined using flow cytom-
etry (Fig. 3, 4).  CD11bloCD11c＋cells are likely CD11blo 
DCs, and CD11bhiCD11c＋cells may include CD11bhi DCs, 
alveolar macrophages and monocyte-derived cells that are 
recruited to the tissue during inflammation  [16, 17].  The 
total number of lung-infiltrating cells significantly increased 
in mice treated with LPS 2 days after administration (Fig. 4). 
In UT12-treated mice, there was a general trend towards in-
creased cell numbers, but it was not statistically significant. 
The proportions of neutrophils and CD11bhiCD11c＋cells 
(mostly monocyte-derived DCs and alveolar macrophages) 
relative to the total number of infiltrating cells increased sig-
nificantly in both LPS- and UT12-treated mice. The increase 
in neutrophils was much higher in LPS-treated mice, while 
the number of CD11bhiCD11c＋cells was similar between 
both treatments. The numbers of CD11bloCD11c＋cells 
(mostly conventional DCs) were not significantly different 
between the treatments, while their proportions in the total 
number of lung cells was reduced due to the increase in neu-
trophils and CD11bhiCD11c＋cells. The number of T and B 
cells in the lung did not change 2 days after either treatment. 
Seven days after the stimulation, the proportions and 
absolute numbers of neutrophils, CD11bloCD11c＋cells, 
CD11bhiCD11c＋cells, and lymphocytes (both T and B cells) 
in mice treated with either LPS or UT12 returned to levels 






























Figure 1 LPS- and UT12-induced cytokine production in the 
RAW264.7 macrophage cell line. 
　RAW264.7 cells were cultured for 24 h in the presence of dif-
ferent concentrations of UT12 (open bar) or LPS (closed bar). 
IL-6 and IL-12 levels in the supernatant were determined by ELI-
SA. (Unpaired t-test: * ＜ 0.05, ** ＜ 0.01)  Note that cytokine 
production by macrophage cell line in response to LPS was higher 
than that in response to UT12.
Figure 2 Increase in pulmonary infiltrating cells after intratra-
cheal administration of LPS or UT12.
　B6 mice received UT12 (closed circle) or LPS (open circle) by 
intratracheal administration. Mice were sacrificed 48 h later, and 
total numbers of cells extracted from the lung were determined 
(left panel). Lung cells were stained for granulocyte marker, Gr1, 
and the proportion of Gr1 ＋ cells (mostly neutrophils) in the total 
pulmonary cell population was determined by flow cytometry. Un-
paired t t st: * ＜ 0.05. Note that the number of neutrophils that 
are recruited into lung in response to LPS and UT12 was different.
























































Figure 3 Flow cytometry analysis of lung-infiltrating cells after intratracheal administration of LPS or UT12. 
　B6 mice received saline (NS), LPS, or UT12 by intratracheal instillation. After 2 and 7 days, cells were extracted 
from lung tissue, stained for Gr1/F4/80, CD11b/CD11c, or TCRβ/B220, and were analyzed by flow cytometry. Gr1/F4/80 
and CD11b/CD11c are shown after large gating in FSC/SSC, and TCRβ/B220 are shown after small lymphocyte gating 
in FSC/SSC. The numbers in the Gr1+/F4/80- (neutrophils), CD11blo/CD11c+ (mostly conventional DCs), and CD11bhi/
CD11c+ (mostly monocyte-derived DCs and alveolar macrophages) flow cytometry profiles indicate the proportions (%) 
of gated cells in dot plots. The numbers in the TCR/B220 (T cells and B cells) profile indicate the proportions of cells in 
the upper left and lower right quadrants.  Note that the proportions of neutrophils and CD11bhi/CD11c+ cells increased in 




















Figure 4 Pulmonary infiltrating cells after intratracheal administration of LPS or UT12.
　B6 mice received saline (NS), LPS, or UT12 by intratracheal instillation. Lung-infiltrating cells were stained with mAbs 2 and 7 
days after treatment and were analyzed by flow cytometry as shown in Figure 3. The proportions and total numbers of Gr1+F4/80- 
(neutrophils), CD11bloCD11c+ (mostly conventional DCs), CD11bhiCD11c+ (mostly monocyte-derived DCs and alveolar mac-
rophages), TCR+B220- (T cells), and TCR- B220 ＋ (B cells) cells in each individual mouse were plotted. The horizontal bar in each 
graph indicates the mean value. ANOVA followed by Holm-Sidaks multiple comparisons test: * ＜ 0.05, ** ＜ 0.01.  Note that the 
increase in neutrophil numbers in LPS-treated mice was larger than that in UT12-treated mice, while the increase in CD11bhi
CD11c+ cells was similar in both groups. 
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3.3 Infiltrating cells in the lung of TRIF -/- and MyD88 -/- 
mice after administration of LPS or UT12
　MyD88 and TRIF are adapter molecules involved in criti-
cal branching points of TLR4 signal transduction. The 
MyD88-mediated pathway induces cytokine production and 
expression of co-stimulatory molecules, while the TRIF-
mediated pathway is critical for the induction of type I inter-
feron [18]. It is controversial which signal transduction path-
way is more important for the onset and exacerbation of 
ARDS [19-21]. To examine the roles of these adaptor mole-
cules in immune cell infiltration of the lung, MyD88-/- and 
TRIF-/- mice were treated with LPS or UT12 via the intratra-
cheal route. Two days after the administration, cells infiltrat-
ing the lung were analyzed using flow cytometry (Fig. 5). In 
MyD88-/- mice, the numbers of Gr1+F4/80− cells (neutro-
phils), CD11bloCD11c＋cells (mostly conventional DCs), 
CD11bhiCD11c＋cells (mostly monocyte-derived DCs and 
alveolar macrophages), and TCR+ cells (T cells) did not sig-
nificantly increase in mice treated with either LPS or UT12, 
when compared with the control saline-treated group. In 
TRIF-/- mice, the total number of lung-infiltrating cells as 
well as those of Gr1+F4/80− cells and CD11bhiCD11c＋cells 
increased after administration of LPS or UT12, in a manner 
similar to those in B6 wild-type mice. These results suggest 
that the MyD88-mediated signaling pathway, but not the 
TRIF-mediated signaling pathway, plays a pivotal role in the 
recruitment of neutrophils and inflammatory cells to the lung 
tissue after intra-tracheal administration of both LPS and 
UT12.
Discussion
　Instillation of LPS into the lung induces recruitment of 
immune cells to the pulmonary tissue. We investigated the 




































































Figure 5 Pulmonary infiltrating cells did not increase in MyD88-/- mice after intratracheal administration of LPS or UT12.
　MyD88-/- and TRIF-/- mice received saline (NS), LPS, or UT12 by intratracheal instillation. Two days after the treatment, lung-infil-
trating cells were stained for Gr1/F4/80, CD11b/CD11c, or TCRβ/B220, and were analyzed by flow cytometry as shown in Figure 3 
(higher panel).  Gr1+F4/80- , CD11bloCD11c+, CD11bhiCD11c+ , TCR+B220-, and TCR- B220 ＋ cells represent mostly neutrophis, con-
ventional DCs, monocyte derived DCs, T cells and B cells.  The number of total lung cells and their subpopulations are plotted (lower 
panel). The horizontal bar in each graph indicates the mean value. ANOVA followed by Holm-Sidakʻs multiple comparisons test: * ＜
0.05, ** ＜ 0.01.  Note that the increase in neutrophils  and CD11bhiCD11c+ cells was observed in TRIF-/- but not in Myd88-/- mice.
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methods of TLR4 signaling, LPS and the anti-TLR4 mAb 
UT12 [10]. The macrophage cell line RAW 264.7 produced 
higher levels of cytokines in response to LPS than UT12 
across a wide dose range, confirming the differences in cel-
lular activation via TLR4 by these two distinct stimulations. 
Instillation of LPS induced recruitment of neutrophils in a 
dose-dependent manner, while the effect of UT12 reached a 
maximum level at 1µg and did not further increase at higher 
doses. LPS activates clustering of the TLR/MD2 complex in 
association with LBP and CD14 and thereby induces intrac-
ellular activation signals in lung cells such as pulmonary 
epithelial cells and macrophages, causing the recruitment of 
various immune cell populations to the pulmonary tissue [4, 
5, 8, 9]. In contrast, UT12 triggers the activation signals in a 
manner restricted only by this antibody-receptor complex 
[11]. In addition, the IgG molecule is a relatively stable pro-
tein and has a long half-life in blood [22]. The differences in 
the TLR4 signaling activation by these molecules may deter-
mine the quality of pulmonary cell activation and culminate 
in distinct TLR4-mediated recruitment of neutrophils.   
　Two types of DCs exist in the lung, CD103+CD11blo DCs 
and CD103-CD11bhi DCs, which differ in their tissue distri-
bution, surface marker expression, and function [23-25]. 
CD103+CD11blo DCs reside in the lung mucosa and the vas-
cular wall and are the main DCs to transport inhaled antigen 
to the draining lymph nodes for activation of specific T cells. 
CD103-CD11bhi DCs are mainly present in perivascular re-
gions of the lung and are the major producers of chemokines 
in the lung, both in homeostasis and under inflammatory 
conditions.  In addition, monocyte-derived DCs are rapidly 
recruited to the lung upon inflammation [17, 26].  The num-
ber of CD11bhiCD11c+ cells increased after inoculation of 
UT12 and LPS, which is likely due to the recruitment of 
monocyte-derived DCs into the lung tissue. We did not ob-
serve significant differences in the number of CD11bloCD11c+ 
cells, which are mostly resident conventional DCs, after ad-
ministration of UT12 or LPS. Thus, the effect of TLR signal-
ing on the recruitment of immune cells to the pulmonary tis-
sue differs between cell types. Instillation of LPS induced a 
higher neutrophil recruitment than UT12, while both treat-
ments induced similar numbers of monocyte-derived DCs 
(CD11chiCD11c+ cells).  
　Chemokines and their receptors are known to play crucial 
roles in the recruitment of inflammatory cells to the lung 
[27]. The recruitment of neutrophils in response to TLR 
stimulation occurs in two phases [28]. The first wave peaks 
at day 1 and is dependent on CXCL1 and CXCL2, which 
both bind to chemokine receptor CXCR2 on neutrophils 
[29]. The second wave is a persistent influx of neutrophils, 
and may depend on CXCL12 binding to its receptor CXCR4 
[30]. Monocyte-derived CD11bhi DCs express CCR6 and 
when recruited to lung tissue, they are induced to express 
CXCL12 and CCL20 after LPS exposure [26, 31]. Thus, one 
possibility to account for the differential effects of LPS and 
UT12 on the recruitment of neutrophils and monocyte-de-
rived DCs is the difference in chemokine production of the 
lung. LPS may induce CXCL1, CXCL2, or CXCL12 at lev-
els higher than UT12, recruiting more neutrophils, while 
both signals may induce similar levels of CCL20, therefore 
recruiting similar levels of monocyte-derived DCs. Alterna-
tively, the levels of CCL20 induced by LPS and UT12 were 
initially different but reached a threshold level of CCR6 sig-
naling, thus recruiting similar numbers of monocyte-derived 
DCs  following both stimulations. Further studies on the 
chemokines and their receptors that are induced by LPS and 
UT12 may help our understanding of the differences and 
similarities of immune cell populations recruited to pulmo-
nary tissue following administration of LPS or UT12. 
　TLR4 signaling branches in two pathways, which are me-
diated by different adapter molecules, MyD88 and TRIF 
[13, 14]. The MyD88 pathway is shared by all TLRs except 
TLR3, and induces cytokine production as well as activation 
of the antigen-presenting function. The TRIF-pathway acti-
vates IFN-β expression in response to TLR3 and TLR4 li-
gands [32]. The production of chemokines in response to 
TLR stimulation appears to be mediated by both MyD88- 
and TRIF-dependent pathways. The chemokines CXCL1 
and CXCL2 that recruit neutrophils are both produced via 
the MyD88-dependent pathway, while only CXCL2 is in-
duced through the TRIF-dependent pathway [29]. We used 
MyD88-/- and TRIF-/- mice to determine whether TLR4-me-
diated recruitment of immune cells to the lung tissue is me-
diated by the Myd88- or the TRIF-dependent pathway. On 
day 2 after LPS or UT12 administration, neutrophils and 
CD11chiCD11c+ cells, mostly monocyte-derived DCs, were 
recruited to the lung in TRIF-/- mice similarly to the B6 wild-
type mice. In contrast, the immune cell number did not in-
crease in the lung of MyD88-/- mice after either treatment, 
suggesting that the recruitment of neutrophils and monocyte- 
derived DCs to the lung after both LPS and UT12 stimula-
tion depends on the MyD88-mediated pathway.  
　In conclusion, we report that intratracheal instillation of 
LPS induced the recruitment of neutrophils at much higher 
levels compared with UT12 treatment, while the recruitment 
of monocyte-derived DCs did not significantly differ be-
tween both treatments. These features of immune cell re-
cruitment to the lung by different TLR4 stimulations may 
help our understanding of the cellular and molecular mecha-
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nisms underlying accumulation of immune cells in the lung 
that ultimately lead to the pathogenesis of immune response-
mediated lung diseases such as ARDS.  
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